Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McGill University

$105,000.00

Investigating the molecular basis of adrenergic-opioid analgesic synergy

EF 2008-09

Résumé
Inadequate pain relief compromises recovery after surgery or injury, results in more complications, longer hospital stays, greater disability, and potentially long-term pain. Current therapeutic interventions do not always provide adequate pain relief (analgesia). This is due, in part, to the lack of effectiveness of the drugs used or to the development of undesirable side effects that reduce drug tolerability. Many analgesic drugs act on a family of receptors called the G-protein coupled receptors to inhibit pain signals in sensory neurons. For example, opiates such as morphine target receptors that are members of this family. When combined with drugs that target other family members such as the adrenergic receptors, a synergistic interaction often occurs. Synergy is useful in clinical pain management as it makes production of analgesia possible at lower doses of each drug, thus reducing undesired side effects and improving treatment outcomes. Although the phenomenon of synergistic analgesic interactions is well described, the mechanisms are not clear. We propose to study the molecular mechanisms underlying opioid-adrenergic synergy. Candidate receptors mediating this effect have been identified and their extensive co-localization in sensory neurons has been demonstrated. We hypothesize that co-expression of these receptors is necessary for their synergistic interaction. We will study the impact of receptor co-expression on their pharmacology, trafficking and ability to form multimeric complexes. Our studies will provide a better understanding of the molecular mechanisms of analgesic synergy and will facilitate the development of combination therapies. The information gained from these studies could result in improved strategies for the treatment of pain with reduced side-effect liability and increased effectiveness.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
184742
Name
Chabot-Doré Anne-Julie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating the molecular basis of adrenergic-opioid analgesic synergy
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Analgesia; Confocal Microscopy; Drug Interactions; G-Protein Coupled Receptors; Heteromer; Immunoprecipitation; Radioligand Binding; Sensory Neurons; Spinal Cord; Synergy
Abstract
Inadequate pain relief compromises recovery after surgery or injury, results in more complications, longer hospital stays, greater disability, and potentially long-term pain. Current therapeutic interventions do not always provide adequate pain relief (analgesia). This is due, in part, to the lack of effectiveness of the drugs used or to the development of undesirable side effects that reduce drug tolerability. Many analgesic drugs act on a family of receptors called the G-protein coupled receptors to inhibit pain signals in sensory neurons. For example, opiates such as morphine target receptors that are members of this family. When combined with drugs that target other family members such as the adrenergic receptors, a synergistic interaction often occurs. Synergy is useful in clinical pain management as it makes production of analgesia possible at lower doses of each drug, thus reducing undesired side effects and improving treatment outcomes. Although the phenomenon of synergistic analgesic interactions is well described, the mechanisms are not clear. We propose to study the molecular mechanisms underlying opioid-adrenergic synergy. Candidate receptors mediating this effect have been identified and their extensive co-localization in sensory neurons has been demonstrated. We hypothesize that co-expression of these receptors is necessary for their synergistic interaction. We will study the impact of receptor co-expression on their pharmacology, trafficking and ability to form multimeric complexes. Our studies will provide a better understanding of the molecular mechanisms of analgesic synergy and will facilitate the development of combination therapies. The information gained from these studies could result in improved strategies for the treatment of pain with reduced side-effect liability and increased effectiveness.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Chabot-Doré, Anne-Julie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~